Results 91 to 100 of about 5,521,904 (294)

In silico and in vitro exploration of a tyrosinase for biocatalytic production of catechols

FEBS Open Bio, EarlyView.
Tyrosinase from Ralstonia pseudosolanacearum is a promising biocatalyst for producing valuable catechols from monophenol substrates. This tyrosinase is uniquely suited to this due to its high monophenolase : diphenolase ratio. We combined in silico docking and in vivo kinetic characterisation of this tyrosinase with 11 industrially relevant monophenols,
James Britton, Fang Zhao, Reeta Davis, Meg Walsh, Kevin E O'Connor, David O'Connell, Tanja Narancic   +6 more
wiley   +1 more source

Deep learning enhanced deciphering of brain activity maps for discovery of therapeutics for brain disorders

iScience
Summary: This study presents an artificial intelligence enhanced in vivo screening platform, DeepBAM, which enables deep learning of large-scale whole brain activity maps (BAMs) from living, drug-responsive larval zebrafish for neuropharmacological ...
Xianrui Zhang, Zhen Liu, Xuan Luo, Yi Cao, Wencong Zhang, Honglin Li, Wei Li, Shuk Han Cheng, Stephen J. Haggarty, Xin Wang, Peng Shi   +10 more
doaj   +1 more source

Multidisciplinary Learning Extends Communication Skill, and Helps Cross Cultural Understandings: Biomedical Engineering [PDF]

Journal of Systemics, Cybernetics and Informatics, 2017
The effects of multidisciplinary learning on extension of communication skill and on cross-cultural understandings have been discussed. "Biomedical engineering" is exemplified for the multidisciplinary field, which includes biology, medicine, engineering,
Shigehiro Hashimoto
doaj  

Analysis of uncertainty and variability in finite element computational models for biomedical engineering:characterization and propagation

Frontiers in Bioengineering and Biotechnology, 2016
Computational modeling has become a powerful tool in biomedical engineering thanks to its potential to simulate coupled systems. However, real parameters are usually not accurately known and variability is inherent in living organisms. To cope with this,
Nerea Mangado, Gemma Piella, Jèrôme Noailly, Jordi Pons-Prats, Miguel Ángel González Ballester, Miguel Ángel González Ballester   +5 more
doaj   +1 more source

From patient advocacy to patient‐driven research: Building active partnerships beginning at the bench to reach the bedside

FEBS Open Bio, EarlyView.
Research is strongest when conducted alongside patients, not just about them. Patient research organizations help integrate patient perspectives into research priorities, study design, and scientific meetings, leading to meaningful patient outcomes and development of relevant therapies.
Jenica H. Kakadia, Rachel Heilmann, Maximiliano Barrientos, Laura MacNeill, Ingrid Vallee, Sarah K. Schultz, Patrick O'Donoghue, Angelica A. Moresco, Victoria M. Siu, Ilka U. Heinemann   +9 more
wiley   +1 more source

Identification and characterisation of calcitonin receptor isoforms expressed in glioblastoma derived glioma stem and U‐87 MG cells

FEBS Open Bio, EarlyView.
Glioblastoma cells express calcitonin receptor variants (CT receptor isoforms) that may help them survive stress. Using qPCR, transcript‐specific long‐read nanopore sequencing, immunofluorescence co‐localisation and comparative sequence analysis, this study identifies a novel alternatively spliced CALCR transcript that encodes the CTb receptor isoform ...
Pragya Gupta, Sebastian GB Furness, Tahereh Gharbi, Ric De Paoli‐Iseppi, Shweta S. Joshi, Michael Clark, David L. Hare, Peter Wookey   +7 more
wiley   +1 more source

What is biomedical engineering?: part 2 [Frontiers of biomedical engineering]

, 2008
Educação Superior::Engenharias::Engenharia BiomédicaPresents a course with the professor of Chemical and Biomedical Engineering at Yale University, W. Mark Saltzman about Frontiers of Biomedical Engineering.
Saltzman, W. Mark
core  

What is biomedical engineering?: part 1 [Frontiers of biomedical engineering]

, 2011
Educação Superior::Engenharias::Engenharia BiomédicaPresents a course with the professor of Chemical and Biomedical Engineering at Yale University, W. Mark Saltzman about Frontiers of Biomedical Engineering.
Saltzman, W. Mark
core   +1 more source

Salmonella enterica serovar typhi limits the potency of typhoid toxin and ADP‐ribosylating toxin AB to establish a persistent infection

FEBS Open Bio, EarlyView.
The two catalytic subunits of typhoid toxin dissociate from the holotoxin in the ER of an intoxicated cell, but only CdtB exits the ER to generate immunosuppressive effects. PltA is retained in the ER and sequestered from its cytosolic target, thus allowing the anti‐inflammatory effects of CdtB to promote intestinal colonization.
Maria C. Zabala‐Rodriguez, Juliette K. Tinker, Teresa Frisan, Taj Azarian, Ken Teter   +4 more
wiley   +1 more source

Summer 2012 Biomedical Engineering Newsletter [PDF]

, 2012
Table of Contents Dr. Jeremy Goldman wins a Fulbright Scholarship Research updates Hal Holmes named Goldwater Scholar Top honors at the Undergraduate Expohttps://digitalcommons.mtu.edu/biomedical-newsletters/1000/thumbnail ...
Department of Biomedical Engineering, Michigan Technological University
core